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PROMOTING FOLLOW-UP IN PATIENTS 
WITH NEW PRESCRIPTIONS FOR 
SECOND-GENERATION 
ANTIPSYCHOTICS
An Accessible Informational Pamphlet For Patients and Prescribers
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Family Medicine Clerkship, Autumn 2019
Community Health Centers of Burlington – Riverside
Mentor:  Adam R. Greenlee, MD
• Mental illness is prevalent
• ~1-in-5 adults in high-income countries live with mental illness, from common mental disorders (e.g. 
major depression, anxiety) to serious mental illnesses (e.g. schizophrenia, bipolar affective disorder)1
• People with mental illness frequently have high rates of adverse somatic health factors
• Tobacco and other substance use, physical inactivity, and poor diet2
• Iatrogenic effects of many psychotropic medications contributing to higher rates of chronic medical 
conditions such as diabetes, cardiovascular disease, and thromboembolic events3
• As a result, mental and physical disorders commonly co-exist, leading to higher morbidity 
and mortality in people living with mental illness4
• Such patients have among the greatest needs, but they often receive poorer quality of care 
due to a combination of many factors, including both system and provider issues5
PROBLEM IDENTIFICATION
& DESCRIPTION OF NEED
• Research has consistently demonstrated worse clinical outcomes and higher costs of care 
for patients with mental illness6,7
• This population has an estimated mortality rate that is 2.2 times higher than the general population8
• Health care costs are estimated to be 60–75% higher for those with mental illness than those 
without9
• State mental health agencies (SMHAs) served ~7.1M clients in FY 2012 at a cost of $39.7B10
• These 7.1M clients represent ~21% of the 34.1M people nationwide receiving some form of mental 
health service during FY 201210
• US states are increasingly turning toward their respective SMHAs to meet the mental health needs 
of their populations
• An estimated 4.7% of VT’s adult population lives with serious mental illness11
• 57.7% of this population receives any form of treatment from either the public system or private 
providers11
• VT Department of Mental Health (DMH) served approximately 7K adult clients in FY 201812
• In FY 2013, DMH service expenditure was $182.6M; per capita expenditure, $291.7013
PUBLIC HEALTH COST & UNIQUE COST 
CONSIDERATIONS IN HOST COMMUNITY
• Seven interviews
• Adam R. Greenlee, MD
• double-boarded in Family Medicine & Psychiatry
• Six anonymous patients starting new prescriptions of 
second-generation antipsychotics (SGAs)
• Takeaways from interviews
• “Patients living with both medical and psychiatric 
illnesses are complex”
• “Psychiatric crises bring patients in, not their medical 
issues… Stabilizing [these crises] takes up all of our 
time, and medical issues are left unresolved, without 
agreed upon plans for follow-up.”
• “What are the side effects?”
• “Is there anything I can do about the side effects?”
• “All of the information is so overwhelming!”
• “A handout would be helpful”
COMMUNITY PERSPECTIVE ON ISSUE
& SUPPORT FOR PROJECT
https://www.chcb.org/locations-providers/riverside-health-center/
• Drafted & designed an information pamphlet containing 
information and instructions for patients starting new SGAs 
prescriptions
• Expert medical consultation by Dr. Greenlee
• Art direction & consultation by Kansas City-based artist and graphic 
designer Dave Coates
• Pamphlets designed for accessibility –
• “friendly” graphics following line-of-sight principles
• Two versions created –
• English, with hand-lettered font
• Blank template with only graphics, allowing room for typed 
translated text
• To better assist medication concordance, follow-up appointment 
date & time are highlighted14
INTERVENTION & METHODOLOGY
• Created an easy-to-read, clear and 
engaging informational pamphlet for 
patients
• Included information addresses 
common patient concerns:
• SGAs basics and benefits
• Potential side effects
• Plans for patient follow-up
• Resources for psychiatric crises
• Dr. Greenlee consulted with each 
draft iteration
RESULTS & RESPONSE DATA
• Evaluation
• Encourage in-visit distribution of pamphlet to patients receiving new/updated SGA prescriptions
• Useful evaluations would include:
• Tracking of pamphlet distribution to appropriate patients
• Pamphlet utility, as gauged by patient and provider feedback
• Limitations
• Due to the delayed conception of the project, follow-up, concordance and motivational interviewing 
are unable to be followed or assessed at this time
• Two formats printed: English, and blank template for translation via word processor
• Translated versions are reliant upon both accurate translation of technical information and 
stakeholder representative access to word processing
• Patients may not be aware of pamphlet
EVALUATION OF
EFFECTIVENESS & LIMITATIONS
• Follow-up with patients to assess longitudinal SGA 
prescription concordance, rates of complications & 
side effects, and outcomes
• For future iterations of informational pamphlets, 
canvassing patients for opinions and attitudes on 
SGAs would help refine the language used
• If deemed successful and of utility, consider 
expanding this series of informational pamphlets to 
include other classes of therapeutic psychotropic 
agents
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